04/11/2019 T3D Therapeutics raises USD 15 million in funding to initiate its Phase II study in people with mild to moderate AD Science watch
04/11/2019 Bill Gates contributes $10 million award to the Alzheimer’s Association ‘Part the Cloud’ programme Dementia in society
02/11/2019 Shanghai Green Valley Pharmaceuticals gets approval of Oligomannate for mild to moderate Alzheimer's disease in China Science watch
31/10/2019 Sensory device to improve wellbeing for people with advanced dementia captures media attention in Wales Dementia in society
25/10/2019 Neuronet convenes annual event on European research collaboration in Alzheimer’s disease and beyond EU projects
